These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 641844)

  • 21. Evaluation of pancreatic exocrine secretion using 13C-dipeptide (benzoyl-L-tyrosyl-[1-(13)C]alanine) breath test: focusing on pancreatoduodenectomy cases.
    Ishii Y; Kohno T; Ito A; Suzuki S; Kohno T; Takayama T; Asai S
    Pancreas; 2007 Nov; 35(4):313-9. PubMed ID: 18090236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of practolol in renal failure.
    Bodem G; Grieser H; Eichelbaum M; Gugler R
    Eur J Clin Pharmacol; 1974 Jul; 7(4):249-52. PubMed ID: 4853603
    [No Abstract]   [Full Text] [Related]  

  • 23. Kinetics of plasma triglyceride metabolism in normal human subjects. Evidence for heterogeneity of the population.
    Nikkilä EA; Kekki M
    Ann Med Exp Biol Fenn; 1970; 48(4):246-8. PubMed ID: 5492144
    [No Abstract]   [Full Text] [Related]  

  • 24. [Excretion of methotrexate in saliva and sweat. An occupational hygiene evaluation].
    Schrøder H; Jensen KB; Brandsborg M
    Ugeskr Laeger; 1988 Aug; 150(34):2026-9. PubMed ID: 3413888
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of ageing on drug absorption from the gut.
    Castleden CM; Volans CN; Raymond K
    Age Ageing; 1977 Aug; 6(3):138-43. PubMed ID: 899963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetate and energy metabolism during hemodialysis.
    Sigler MH; Skutches CL; Teehan BP; Cooper JH; Reichard GA
    Kidney Int Suppl; 1983 Dec; 16():S97-101. PubMed ID: 6429408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the specificity of the [13C]mixed triacylglycerol breath test by estimating carbon dioxide production from heart rate.
    Slater C; Preston T; Weaver LT
    Eur J Clin Nutr; 2006 Nov; 60(11):1245-52. PubMed ID: 16736067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Viquidil: study of its metabolism by an isotopic method. 3. Excretion and biotransformation in animals].
    Uzan A; Guérémy C
    Arzneimittelforschung; 1974 Jan; 24(1):34-9. PubMed ID: 4406106
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolism studies with practolol [proceedings].
    Case DE; Lindup WE; Lowery C; Orton TC; Reeves PR; Whittaker SE
    Br J Pharmacol; 1978 Jun; 63(2):352P. PubMed ID: 96899
    [No Abstract]   [Full Text] [Related]  

  • 30. Ascorbic acid metabolism in man.
    Baker EM; Saari JC; Tolbert BM
    Am J Clin Nutr; 1966 Dec; 19(6):371-8. PubMed ID: 5954013
    [No Abstract]   [Full Text] [Related]  

  • 31. The distribution and irreversible tissue binding of practolol and its metabolites in the hamster [proceedings].
    Lindup WE; Longshaw S; Orton TC; Whittaker SE
    Br J Pharmacol; 1979 Jul; 66(3):504P. PubMed ID: 526773
    [No Abstract]   [Full Text] [Related]  

  • 32. Does ampicillin affect practolol kinetics? [proceedings].
    Kelly JG; Leahey WJ; McDevitt DG; Riddell JG
    Br J Clin Pharmacol; 1977 Jun; 4(3):396P. PubMed ID: 901722
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of practolol in plasma by high-performance liquid chromatography.
    Cooper MJ; Mirkin BL
    J Chromatogr; 1979 Jun; 163(2):244-6. PubMed ID: 575538
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.
    Hinderling PH; Schmidlin O; Seydel JK
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):263-87. PubMed ID: 6150103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practolol inhibits human skin fibroblast cell mat hydroxyproline accumulation.
    Elliott GR; Amos HE; Miller K; Bridges JW
    Agents Actions; 1987 Oct; 22(1-2):106-13. PubMed ID: 3687592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practolol metabolism. II. Metabolism in human subjects.
    Reeves PR; Case DE; Jepson HT; McCormick DJ; Nicholls JT; Felix RH; Holt PJ; Zacharias FJ; Fluke RW
    J Pharmacol Exp Ther; 1978 May; 205(2):489-98. PubMed ID: 641844
    [No Abstract]   [Full Text] [Related]  

  • 37. Biliary excretion and enterohepatic recirculation of practolol in man.
    Carruthers SG; Kelly JG; Johnson GW; McDevitt DG
    Ir J Med Sci; 1976 Jun; 145(6):187-94. PubMed ID: 939682
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM; Kumana CR; Franklin DA; Baker LR
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolism and distribution of the selective adrenergic beta blocking agent, practolol.
    Scales B; Cosgrove MB
    J Pharmacol Exp Ther; 1970 Nov; 175(2):338-47. PubMed ID: 4394800
    [No Abstract]   [Full Text] [Related]  

  • 40. Alteration of bile acid metabolism by cimetidine in healthy humans.
    Shindo K; Yamazaki R; Koide K; Fukumura M; Hirai Y
    J Investig Med; 1996 Oct; 44(8):462-9. PubMed ID: 8952227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.